Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Cline, Vivian J
LIBRETTO-432, NCT04819100 / 2020-005191-35: A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)	Recruiting	3	170	Europe, Canada, Japan, US, RoW	Selpercatinib, LY3527723, LOXO-292, Placebo	Loxo Oncology, Inc., Eli Lilly and Company	Carcinoma, Non-Small-Cell Lung	05/27	08/32
COMPANION-002, NCT05506943: A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers	Active, not recruiting	2/3	150	US	CTX-009, Paclitaxel	Compass Therapeutics	Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer, Ampullary Cancer	07/25	12/25
GRANITE, NCT05141721: A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer	Active, not recruiting	2/3	700	US	GRT-C901, GRT-R902, Atezolizumab, Tecentriq, Ipilimumab, Yervoy, Fluoropyrimidine plus leucovorin, Xeloda, Bevacizumab, Avastin	Gritstone bio, Inc.	Colorectal Neoplasms	03/27	03/27
SGN35-015, NCT01716806 / 2019-003982-17: A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL) Additional data for front-line Hodgkin's lymphoma in elderly patients (ASH 2014) Nov 2014 - Nov 2014: Additional data for front-line Hodgkin's lymphoma in elderly patients (ASH 2014) For newly diagnosed Hodgkin's lymphoma in elderly patients Dec 2013 - Dec 2013: For newly diagnosed Hodgkin's lymphoma in elderly patients Elderly chemo-intolerant Hodgkin's lymphoma patients Nov 2013 - Nov 2013: Elderly chemo-intolerant Hodgkin's lymphoma patients Presentation of data from front line Hodgkin's lymphoma in elderly patients at ASH 2013 Nov 2013 - Nov 2013: Presentation of data from front line Hodgkin's lymphoma in elderly patients at ASH 2013 ASH 2013 Nov 2013 - Nov 2013: ASH 2013 More	Completed	2	131	Canada, US	brentuximab vedotin, Adcetris; SGN-35, bendamustine, dacarbazine, nivolumab	Seagen Inc., Bristol-Myers Squibb	Hodgkin Disease, Peripheral T Cell Lymphoma	04/23	09/23
C-800-25, NCT05608044: A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer	Active, not recruiting	2	234	Europe, US, RoW	Botensilimab, AGEN1181, Balstilimab, AGEN2034, Standard of Care	Agenus Inc.	Metastatic Colorectal Cancer	02/25	07/25
GRECO-2, NCT04698915: Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer	Terminated	2	177	Europe, Canada, US	Drug GC4711, Placebo	Galera Therapeutics, Inc.	SBRT, Borderline Resectable Pancreatic Cancer, Unresectable Pancreatic Cancer	11/23	11/23
Schany, Christi
No trials found